Large Domains of Heterochromatin Direct the Formation of Short Mitotic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Wellcome Four Year Phd Programme in Integrative Cell Mechanisms
2021 Wellcome Four Year PhD Programme in Integrative Cell Mechanisms Training the next generation of Molecular Cell Biologists Background and Aims of Programme The Wellcome Four Year PhD Programme in Integrative Cell Mechanisms (iCM) is closely associated with the Wellcome Centre for Cell Biology and trains the next generation of cell and molecular biologists in the application of quantitative methods to understand the inner workings of distinct cell types in different settings. A detailed understanding of normal cellular function is required to investigate the molecular cause of disease and design future treatments. However, data generated by biological research requires increasingly complex analysis with technological advances in sequencing, mass spectrometry/proteomics, super-resolution microscopy, Wellcome Centre for Cell Biology 2021 synthetic and structural biology generating increasingly large, complex datasets. In addition, innovations in computer sciences and informatics are transforming data acquisition and analysis and breakthroughs in physics, chemistry and engineering allow the development of devices, molecules and instruments that drive the biological data revolution. Exploiting technological advances to transform our understanding of cellular mechanisms will require scientists who have been trained across the distinct disciplines of natural sciences, engineering, informatics and mathematics. To address this training need, iCM PhD projects are cross-disciplinary involving two primary supervisors with complementary expertise. Supervisor partnerships pair quantitative scientists with cell biologists ensuring that students develop pioneering cross-disciplinary collaborative projects to uncover cellular mechanisms relevant to health and disease. We aim to recruit students with a variety of backgrounds across the biological and physical sciences, including Biochemistry, Biomedical Science, Cell Biology, Chemistry, Computational Data Sciences, Engineering, Genetics, Mathematics, Molecular Biology and Physics. -
Genome Analysis and Knowledge
Dahary et al. BMC Medical Genomics (2019) 12:200 https://doi.org/10.1186/s12920-019-0647-8 SOFTWARE Open Access Genome analysis and knowledge-driven variant interpretation with TGex Dvir Dahary1*, Yaron Golan1, Yaron Mazor1, Ofer Zelig1, Ruth Barshir2, Michal Twik2, Tsippi Iny Stein2, Guy Rosner3,4, Revital Kariv3,4, Fei Chen5, Qiang Zhang5, Yiping Shen5,6,7, Marilyn Safran2, Doron Lancet2* and Simon Fishilevich2* Abstract Background: The clinical genetics revolution ushers in great opportunities, accompanied by significant challenges. The fundamental mission in clinical genetics is to analyze genomes, and to identify the most relevant genetic variations underlying a patient’s phenotypes and symptoms. The adoption of Whole Genome Sequencing requires novel capacities for interpretation of non-coding variants. Results: We present TGex, the Translational Genomics expert, a novel genome variation analysis and interpretation platform, with remarkable exome analysis capacities and a pioneering approach of non-coding variants interpretation. TGex’s main strength is combining state-of-the-art variant filtering with knowledge-driven analysis made possible by VarElect, our highly effective gene-phenotype interpretation tool. VarElect leverages the widely used GeneCards knowledgebase, which integrates information from > 150 automatically-mined data sources. Access to such a comprehensive data compendium also facilitates TGex’s broad variant annotation, supporting evidence exploration, and decision making. TGex has an interactive, user-friendly, and easy adaptive interface, ACMG compliance, and an automated reporting system. Beyond comprehensive whole exome sequence capabilities, TGex encompasses innovative non-coding variants interpretation, towards the goal of maximal exploitation of whole genome sequence analyses in the clinical genetics practice. This is enabled by GeneCards’ recently developed GeneHancer, a novel integrative and fully annotated database of human enhancers and promoters. -
EMBO Conference on Fission Yeast: Pombe 2013 7Th International Fission Yeast Meeting London, United Kingdom, 24 - 29 June 2013
Abstracts of papers presented at the EMBO Conference on Fission Yeast: pombe 2013 7th International Fission Yeast Meeting London, United Kingdom, 24 - 29 June 2013 Meeting Organizers: Jürg Bähler UCL, UK Jacqueline Hayles CRUK-LRI, UK Scientific Programme: Robin Allshire UK Rob Martienssen USA Paco Antequera Spain Hisao Masai Japan Francois Bachand Canada Jonathan Millar UK Jürg Bähler UK Sergio Moreno Spain Pernilla Bjerling Sweden Jo Murray UK Fred Chang USA Toru Nakamura USA Gordon Chua Canada Chris Norbury UK Peter Espenshade USA Kunihiro Ohta Japan Kathy Gould USA Snezhka Oliferenko Singapore Juraj Gregan Austria Janni Petersen UK Edgar Hartsuiker UK Paul Russell USA Jacqueline Hayles UK Geneviève Thon Denmark Elena Hidalgo Spain Iva Tolic-Nørrelykke Germany Charlie Hoffman USA Elizabeth Veal UK Zoi Lygerou Greece Yoshi Watanabe Japan Henry Levin USA Jenny Wu France These abstracts may not be cited in bibliographies. Material contained herein should be treated as personal communication and should be cited as such only with the consent of the authors. Printed by SLS Print, London, UK Page 1 Poster Prize Judges: Coordinated by Sara Mole & Mike Bond UCL, UK Poster Prizes sponsored by UCL, London’s Global University Rosa Aligué Spain Hiroshi Murakami Japan José Ayté Spain Eishi Noguchi USA Hugh Cam USA Martin Převorovský Czech Republic Rafael Daga Spain Luis Rokeach Canada Jacob Dalgaard UK Ken Sawin UK Da-Qiao Ding Japan Melanie Styers USA Tim Humphrey UK Irene Tang USA Norbert Käufer Germany Masaru Ueno Japan Makoto Kawamukai Japan -
The Mouse Genome Database: Integration of and Access to Knowledge About the Laboratory Mouse Judith A
D810–D817 Nucleic Acids Research, 2014, Vol. 42, Database issue Published online 26 November 2013 doi:10.1093/nar/gkt1225 The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse Judith A. Blake*, Carol J. Bult, Janan T. Eppig, James A. Kadin and Joel E. Richardson The Mouse Genome Database Groupy Bioinformatics and Computational Biology, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA Received October 1, 2013; Revised November 4, 2013; Accepted November 5, 2013 ABSTRACT genes and as a comprehensive data integration site and repository for mouse genetic, genomic and phenotypic The Mouse Genome Database (MGD) (http://www. data derived from primary literature as well as from informatics.jax.org) is the community model major data providers (1,2). organism database resource for the laboratory The central mission of the MGD is to support the trans- mouse, a premier animal model for the study of lation of information from experimental mouse models to genetic and genomic systems relevant to human uncover the genetic basis of human diseases. As a highly biology and disease. MGD maintains a comprehen- curated and comprehensive model organism database, sive catalog of genes, functional RNAs and other MGD provides web and programmatic access to a genome features as well as heritable phenotypes complete catalog of mouse genes and genome features and quantitative trait loci. The genome feature including genomic sequence and variant information. catalog is generated by the integration of computa- MGD curates and maintains the comprehensive listing of functional annotations for mouse genes using Gene tional and manual genome annotations generated Ontology (GO) terms and contributes to the development by NCBI, Ensembl and Vega/HAVANA. -
Laboratory Harbor Spring Cold Annual Report 1990
YEAR CENTENNIAL THE LABORATORY HARBOR SPRING COLD ANNUAL REPORT 1990 COLD SPRING HARBOR LABORATORY THE CENTENNIAL YEAR ANNUAL REPORT 1990 Cold Spring Harbor Laboratory Box 100 1 Bungtown Road Cold Spring Harbor, New York 11724 Book design Emily Harste Editors Dorothy Brown, Lee Martin Photography Margot Bennett, Herb Parsons, Edward Campodonico Typography Marie Sullivan Front cover: Jones Laboratory, during the Centennial fireworks dis- play. This building, completed in 1893, was the first structure built expressly for science at Cold Spring Harbor. (Photograph by Ross Meurer and Margot Bennett.) Back Cover: (Top) Centennial reenactment of the first biology class at Cold Spring Harbor on board the launch "Rotifer." (Inset) The original class of 1890. Reenactments for the Centennial were directed by Rob Gensel. (Photograph by Randy Wilfong.) (Bottom) Centennial reenactment of the Laboratory's first biology class on the Jones Laboratory porch. (Inset) The original 1890 class on the porch of the old Fish Hatchery building before the completion of Jones Laboratory. (Photograph by Margot Bennett.) Contents Officers of the Corporation/Board of Trustees v Governance and Major Affiliations vi Committees vii Edward Pulling (1898-1991)viii DIRECTOR'S REPORT DEPARTMENTAL REPORTS 21 Administration 23 Buildings and Grounds 25 Development 28 Library Services 30 Public Affairs 32 RESEARCH 35 Tumor Viruses 37 Molecular Genetics of Eukaryotic Cells 93 Genetics 155 Structure and Computation 197 Neuroscience 213 CSH Laboratory Junior Fellows217 COLD SPRING -
Mouse Genome Database (MGD): Knowledgebase for Mouse- Human Comparative Biology
The Jackson Laboratory The Mouseion at the JAXlibrary Faculty Research 2021 Faculty Research 1-8-2021 Mouse Genome Database (MGD): Knowledgebase for mouse- human comparative biology. Judith A. Blake Richard M. Baldarelli James A. Kadin Joel E Richardson Cynthia Smith See next page for additional authors Follow this and additional works at: https://mouseion.jax.org/stfb2021 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons Authors Judith A. Blake, Richard M. Baldarelli, James A. Kadin, Joel E Richardson, Cynthia Smith, Carol J Bult, and Mouse Genome Database Group Published online 24 November 2020 Nucleic Acids Research, 2021, Vol. 49, Database issue D981–D987 doi: 10.1093/nar/gkaa1083 Mouse Genome Database (MGD): Knowledgebase for mouse–human comparative biology Judith A. Blake *, Richard Baldarelli, James A. Kadin, Joel E. Richardson, Cynthia L. Smith , Carol J. Bult and the Mouse Genome Database Group The Jackson Laboratory, Bar Harbor, ME, USA Downloaded from https://academic.oup.com/nar/article/49/D1/D981/5999894 by Jackson Laboratory user on 28 January 2021 Received September 15, 2020; Revised October 18, 2020; Editorial Decision October 19, 2020; Accepted November 22, 2020 ABSTRACT lying human biology and disease. MGD serves three ma- jor user communities: (i) biomedical researchers who use The Mouse Genome Database (MGD; http://www. mouse experimentation to investigate genetic and molecu- informatics.jax.org) is the community model organ- lar principles of biology and disease processes, (ii) transla- ism knowledgebase for the laboratory mouse, a tional scientists who use the laboratory mouse to model hu- widely used animal model for comparative studies man disease and (iii) bioinformaticians/computational bi- of the genetic and genomic basis for human health ologists who use the rich integrated data MGD provides to and disease. -
Mouse Genome Informatics (MGI) Resource: Genetic, Genomic, and Biological Knowledgebase for the Laboratory Mouse Janan T
ILAR Journal, 2017, Vol. 58, No. 1, 17–41 doi: 10.1093/ilar/ilx013 Article Mouse Genome Informatics (MGI) Resource: Genetic, Genomic, and Biological Knowledgebase for the Laboratory Mouse Janan T. Eppig Janan T. Eppig, PhD, is Professor Emeritus at The Jackson Laboratory in Bar Harbor, Maine. Address correspondence to Dr. Janan T. Eppig, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 or email [email protected] Abstract The Mouse Genome Informatics (MGI) Resource supports basic, translational, and computational research by providing high-quality, integrated data on the genetics, genomics, and biology of the laboratory mouse. MGI serves a strategic role for the scientific community in facilitating biomedical, experimental, and computational studies investigating the genetics and processes of diseases and enabling the development and testing of new disease models and therapeutic interventions. This review describes the nexus of the body of growing genetic and biological data and the advances in computer technology in the late 1980s, including the World Wide Web, that together launched the beginnings of MGI. MGI develops and maintains a gold-standard resource that reflects the current state of knowledge, provides semantic and contextual data integration that fosters hypothesis testing, continually develops new and improved tools for searching and analysis, and partners with the scientific community to assure research data needs are met. Here we describe one slice of MGI relating to the development of community-wide large-scale mutagenesis and phenotyping projects and introduce ways to access and use these MGI data. References and links to additional MGI aspects are provided. Key words: database; genetics; genomics; human disease model; informatics; model organism; mouse; phenotypes Introduction strains and special purpose strains that have been developed The laboratory mouse is an essential model for understanding provide fertile ground for population studies and the potential human biology, health, and disease. -
Epigenetic Gene Silencing by Heterochromatin Primes Fungal Resistance
bioRxiv preprint doi: https://doi.org/10.1101/808055; this version posted October 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Epigenetic gene silencing by heterochromatin primes fungal resistance Sito Torres-Garcia, Pauline N. C. B. Audergon†, Manu Shukla, Sharon A. White, Alison L. Pidoux, Robin C. Allshire* Wellcome Centre for Cell Biology and Institute of Cell Biology, School of Biological Sciences, The University of Edinburgh, Mayfield Road, Edinburgh EH9 3BF, UK. † Present address: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona 08003, Spain * Corresponding author: E-mail: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/808055; this version posted October 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Summary: 2 Genes embedded in H3 lysine 9 methylation (H3K9me)–dependent 3 heterochromatin are transcriptionally silenced1-3. In fission yeast, 4 Schizosaccharomyces pombe, H3K9me heterochromatin silencing can be 5 transmitted through cell division provided the counteracting demethylase Epe1 6 is absent4,5. It is possible that under certain conditions wild-type cells might 7 utilize heterochromatin heritability to form epimutations, phenotypes mediated 8 by unstable silencing rather than changes in DNA6,7. Here we show that resistant 9 heterochromatin-mediated epimutants are formed in response to threshold 10 levels of the external insult caffeine. ChIP-seq analyses of unstable resistant 11 isolates revealed new distinct heterochromatin domains, which in some cases 12 reduce the expression of underlying genes that are known to confer resistance 13 when deleted. -
Directory 2016/17 the Royal Society of Edinburgh
cover_cover2013 19/04/2016 16:52 Page 1 The Royal Society of Edinburgh T h e R o Directory 2016/17 y a l S o c i e t y o f E d i n b u r g h D i r e c t o r y 2 0 1 6 / 1 7 Printed in Great Britain by Henry Ling Limited, Dorchester, DT1 1HD ISSN 1476-4334 THE ROYAL SOCIETY OF EDINBURGH DIRECTORY 2016/2017 PUBLISHED BY THE RSE SCOTLAND FOUNDATION ISSN 1476-4334 The Royal Society of Edinburgh 22-26 George Street Edinburgh EH2 2PQ Telephone : 0131 240 5000 Fax : 0131 240 5024 email: [email protected] web: www.royalsoced.org.uk Scottish Charity No. SC 000470 Printed in Great Britain by Henry Ling Limited CONTENTS THE ORIGINS AND DEVELOPMENT OF THE ROYAL SOCIETY OF EDINBURGH .....................................................3 COUNCIL OF THE SOCIETY ..............................................................5 EXECUTIVE COMMITTEE ..................................................................6 THE RSE SCOTLAND FOUNDATION ..................................................7 THE RSE SCOTLAND SCIO ................................................................8 RSE STAFF ........................................................................................9 LAWS OF THE SOCIETY (revised October 2014) ..............................13 STANDING COMMITTEES OF COUNCIL ..........................................27 SECTIONAL COMMITTEES AND THE ELECTORAL PROCESS ............37 DEATHS REPORTED 26 March 2014 - 06 April 2016 .....................................................43 FELLOWS ELECTED March 2015 ...................................................................................45 -
22Q11.2 Duplications North Carolina, 27526, Ontario, USA Canada on P4N 6N5 Tel +1 (919) 567-8167 [email protected] Or [email protected]
Support and Information Rare Chromosome Disorder Support Group The Stables, Station Road West, Oxted, Surrey RH8 9EE, United Kingdom Tel: +44(0)1883 723356 [email protected] I www.rarechromo.org Join Unique for family links, information and support. Unique is a charity without government funding, existing entirely on donations and grants. If you can, please make a donation via our website at www.rarechromo.org/donate Please help us to help you! Chromosome 22 Central www.c22c.org or c/o Murney Rinholm, c/o Stephanie St-Pierre, 7108 Partinwood Drive, 338 Spruce Street North, Fuquay-Varina, Timmins, 22q11.2 duplications North Carolina, 27526, Ontario, USA Canada ON P4N 6N5 Tel +1 (919) 567-8167 [email protected] or [email protected] Facebook www.facebook.com/groups/214854295210303 This guide was developed by Unique with generous support from the James Tudor Foundation. Unique lists external message boards and websites in order to be helpful to families looking for information and support. This does not imply that we endorse their content or have any responsibility for it. This information guide is not a substitute for personal medical advice. Families should consult a medically qualified clinician in all matters relating to genetic diagnosis, management and health. Information on genetic changes is a very fast-moving field and while the information in this guide is believed to be the best available at the time of publication, some facts may later change. Unique does its best to keep abreast of changing information and to review its published guides as needed. The guide was compiled by Unique and reviewed by Dr Melissa Carter, Clinical Geneticist specializing in developmental disabilities at The Hospital for Sick Children in Toronto, Canada , and by Professor Maj Hultén, Professor of Medical Genetics, University of Warwick, UK and Karolinska Institutet, Stockholm, Sweden. -
LARGE Expression in Different Types of Muscular Dystrophies Other Than Dystroglycanopathy Burcu Balci-Hayta1*, Beril Talim2, Gulsev Kale2 and Pervin Dincer1
Balci-Hayta et al. BMC Neurology (2018) 18:207 https://doi.org/10.1186/s12883-018-1207-0 RESEARCHARTICLE Open Access LARGE expression in different types of muscular dystrophies other than dystroglycanopathy Burcu Balci-Hayta1*, Beril Talim2, Gulsev Kale2 and Pervin Dincer1 Abstract Background: Alpha-dystroglycan (αDG) is an extracellular peripheral glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin globular domains and certain arenaviruses. An important enzyme, known as Like-acetylglucosaminyltransferase (LARGE), has been shown to transfer repeating units of -glucuronic acid-β1,3-xylose-α1,3- (matriglycan) to αDG that is required for functional receptor as an extracellular matrix protein scaffold. The reduction in the amount of LARGE-dependent matriglycan result in heterogeneous forms of dystroglycanopathy that is associated with hypoglycosylation of αDG and a consequent lack of ligand-binding activity. Our aim was to investigate whether LARGE expression showed correlation with glycosylation of αDG and histopathological parameters in different types of muscular dystrophies, except for dystroglycanopathies. Methods: The expression level of LARGE and glycosylation status of αDG were examined in skeletal muscle biopsies from 26 patients with various forms of muscular dystrophy [Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), sarcoglycanopathy, dysferlinopathy, calpainopathy, and merosin and collagen VI deficient congenital muscular dystrophies (CMDs)] and correlation of results with different histopathological features was investigated. Results: Despite the fact that these diseases are not caused by defects of glycosyltransferases, decreased expression of LARGE was detected in many patient samples, partly correlating with the type of muscular dystrophy. Although immunolabelling of fully glycosylated αDG with VIA4–1 was reduced in dystrophinopathy patients, no significant relationship between reduction of LARGE expression and αDG hypoglycosylation was detected. -
Centromere Repositioning Causes Inversion of Meiosis and Generates a Reproductive Barrier
Centromere repositioning causes inversion of meiosis and generates a reproductive barrier Min Lua and Xiangwei Hea,1 aMinistry of Education Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, 310058 Hangzhou, Zhejiang, China Edited by J. Richard McIntosh, University of Colorado, Boulder, CO, and approved September 20, 2019 (received for review July 10, 2019) The chromosomal position of each centromere is determined postulated that a neocentromere may seed the formation of an epigenetically and is highly stable, whereas incremental cases ENC at a site devoid of satellite DNA, which is then matured have supported the occurrence of centromere repositioning on an through acquisition of repetitive DNA. ENCs and neocentromeres evolutionary time scale (evolutionary new centromeres, ENCs), are considered as two sides of the same coin, manifestations of the which is thought to be important in speciation. The mechanisms same biological phenomenon at drastically different time scales underlying the high stability of centromeres and its functional and population sizes (7). Hence, understanding centromere repo- significance largely remain an enigma. Here, in the fission yeast sitioning may provide mechanistic insights into ENC emergence Schizosaccharomyces pombe, we identify a feedback mechanism: and progression. The kinetochore, whose assembly is guided by the centromere, in CENP-A–containing chromatin directly recruits specific com- turn, enforces centromere stability. Upon going through meiosis, ponents of the kinetochore, called the constitutive centromere- specific inner kinetochore mutations induce centromere reposi- associated network. The kinetochore is a proteinaceous ma- tioning—inactivation of the original centromere and formation chinery comprised of inner and outer parts, each compassing of a new centromere elsewhere—in 1 of the 3 chromosomes at several subcomplexes.